Enhancing Antitumor Efficacy by Simultaneous ATP-Responsive Chemodrug Release and Cancer Cell Sensitization Based on

Xiao-Rong Song1,2, Shi-Hua Li2, Hanhan Guo1

  • 1CAS Key Laboratory of Design and Assembly of Functional Nanostructures Fujian Key Laboratory of Nanomaterials Fujian Institute of Research on the Structure of Matter Chinese Academy of Sciences Fuzhou Fujian 350002 China.

Insights

Engineered smart nanoagents deliver drugs effectively in cancer cells by responding to adenosine triphosphate (ATP). This novel approach enhances chemotherapy by depleting ATP and increasing cancer cell sensitivity, improving treatment outcomes.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapeutics

Background:

  • Smart nanoagents for drug delivery systems (DDSs) show promise in cancer treatment.
  • Current nanoagents face challenges in synthesis, drug release, and cancer cell chemosensitivity.

Purpose of the Study:

  • To engineer an adenosine triphosphate (ATP)-activatable nanoagent for improved cancer chemotherapy.
  • To address limitations of current nanoagents, including complex synthesis and insufficient drug efficacy.

Main Methods:

  • Developed a one-step self-assembly of quantum dots-phenolic nanoclusters into a smart nanoagent.
  • Investigated ATP-activated disassembly and controlled drug delivery mechanisms.
  • Conducted in vitro and in vivo studies for efficacy, imaging, and clearance assessment.

Main Results:

  • The nanoagent demonstrated high drug loading and low cytotoxicity to normal cells.
  • Achieved ATP-activated drug release and induced cancer cell ATP depletion.
  • Showcased enhanced tumor accumulation, intracellular ATP imaging, and body clearance.

Conclusions:

  • The multifunctional nanoagent offers enhanced antitumor efficacy through ATP-responsive drug release and cancer cell sensitization.
  • Provides novel insights for designing advanced nanoagents for cancer therapeutics.
  • Highlights the potential of ATP-activatable systems in improving cancer treatment strategies.

Related Concept Videos

ATP Energy Storage and Release01:31

ATP Energy Storage and Release

ATP is a highly unstable molecule. Unless quickly used to perform work, ATP spontaneously dissociates into ADP and inorganic phosphate (Pi), and the free energy released during this process is lost as heat. The energy released by ATP hydrolysis is used to perform work inside the cell and depends on a strategy called energy coupling. Cells couple the exergonic reaction of ATP hydrolysis with endergonic reactions, allowing them to proceed.
One example of energy coupling using ATP involves a...
14.4K
Hydrolysis of ATP01:08

Hydrolysis of ATP

The bonds of adenosine triphosphate (ATP) can be broken through the addition of water, releasing one or two phosphate groups in an exergonic process called hydrolysis. This reaction liberates the energy in the bonds for use in the cell—for instance, to synthesize proteins from amino acids.
If one phosphate group is removed, a molecule of ADP—adenosine diphosphate—remains, along with inorganic phosphate. ADP can be further hydrolyzed to AMP—adenosine...
81.3K
ATP Yield01:31

ATP Yield

Cellular respiration produces 30 - 32 ATP per glucose molecule. Although most of the ATP results from oxidative phosphorylation and the electron transport chain (ETC), 4 ATP are gained beforehand (2 from glycolysis and 2 from the citric acid cycle).
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...
78.9K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.5K
Energy-releasing Steps of Glycolysis01:28

Energy-releasing Steps of Glycolysis

Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
146.8K
Self-Efficacy01:29

Self-Efficacy

Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
224